<p>Ali Urman, Genomics Analyst at Ark Invest, joins Voices of Wall Street's Market Banter podcast to discuss which companies are best positioned to capitalize on innovation in gene therapy and gene editing. </p>

Ali Urman, Genomics Analyst at Ark Invest, joins Voices of Wall Street's Market Banter podcast to discuss which companies are best positioned to capitalize on innovation in gene therapy and gene editing.

<p>Ali Urman, Genomics Analyst at Ark Invest, joins Voices of Wall Street's Market Banter podcast to discuss which companies are best positioned to capitalize on innovation in gene therapy and gene editing.&nbsp;</p>

Genomics as an Emerging Investment Opportunity

Market Banter is not your average markets podcast. The show brings an intelligent, free-flowing, opinionated, and funny talk show-style approach to the most intriguing news and trends across markets and the economy. Whether you have a Ph.D. in economics or you are just starting to learn about markets, this podcast is for you. Hosted by Dion Rabouin, Markets Editor at Axios, and Dan Enfield, NYC comedian. Produced by Voices of Wall Street.

Share Genomics as an Emerging Investment Opportunity

Sign up to save your podcasts

Genomics as an Emerging Investment Opportunity

Genomics as an Emerging Investment Opportunity